logo
Iteris Technology Selected by City of Corona for Smart Mobility Upgrades

Iteris Technology Selected by City of Corona for Smart Mobility Upgrades

Business Wire30-04-2025
SANTA ANA, Calif.--(BUSINESS WIRE)-- Iteris, Inc., the world's trusted technology ecosystem for smart mobility infrastructure management and part of Almaviva Group, today announced the City of Corona, California has awarded Iteris an over $4 million contract to provide the city with smart mobility infrastructure management technologies.
Corona will utilize Iteris' software as a service (SaaS) solution ClearGuide ® combined with new detection sensors and web-based communication infrastructure. Under the terms of the agreement, the city will have access to ClearGuide Roadways, an easy-to-use dynamic service that helps agencies improve real-time operations, incident management, work zone mobility, and transportation planning with traffic data and map content.
They will also deploy Vantage Apex ®, Iteris' AI-powered HD video and radar detection sensors and VantageLive!®, an easy-to-use, web-based data service that allows users to view activity at their intersections by automatically collecting and analyzing vehicle, bicycle and pedestrian data, removing the need for manual, costly data collection efforts. These technologies will enable Corona to gather more accurate road user detection and counts for several major arterial corridors, which they plan to aggregate to produce new, more efficient coordination patterns. In total, over 100 intersections across the city will benefit from this investment.
'I'm eager to have hi-resolution data readily available in an easy to digest format,' said Aaron M. Cox, PE, TE, PMP, senior engineer of traffic public works at the City of Corona. 'Our team will use this information to make our arterial corridors operate more efficiently, and we're looking forward to working with our partners to make this project happen.'
ClearGuide, Vantage Apex and VantageLive! are all key components of Iteris' ClearMobility® Platform, the world's most complete solution to continuously monitor, visualize and optimize mobility infrastructure. It applies cloud computing, artificial intelligence, advanced sensors, advisory services and managed services to help ensure roads are safe, travel is efficient, and communities thrive.
'We're thrilled to be working with the City of Corona and Crosstown Electrical & Data on this project,' said Adam Cook, senior vice president and chief sales officer at Iteris. 'With these technologies working together, this initiative will ultimately help to increase value, effectiveness and resilience in the city's transportation infrastructure, all while making the roads safer and more efficient for travelers.'
About Iteris, Inc.
Iteris, Inc. is a leading provider of smart mobility infrastructure management solutions and part of the Almaviva Group of businesses serving the transportation and logistics industry. Iteris' cloud-enabled solutions help public transportation agencies, municipalities, commercial entities and other transportation infrastructure providers monitor, visualize, and optimize mobility infrastructure to make mobility safe, efficient, and sustainable. As a pioneer in intelligent transportation systems technology, Iteris' advanced detection sensors, mobility and traffic data, software-as-a-service offerings, and consulting services represent a comprehensive range of mobility infrastructure management solutions that serve customers in North America and around the world.
For more information, visit Iteris' website at www.iteris.com.
About Almaviva Group
Almaviva, an Italian digital innovation group, supports the country's growth processes by embracing the challenges that companies must face in order to remain competitive in the digital age, innovating its own business models, organization, corporate culture, and ICT. With solid made-in-Italy expertise, Almaviva has built a global network consisting of 30 companies and 79 offices in Italy and abroad, with a significant presence in LATAM (Brazil, Colombia, Dominican Republic), as well as in the United States, Belgium, Spain, Finland, Saudi Arabia, the United Arab Emirates, Egypt, and Tunisia. For more information visit www.almaviva.it [almaviva.it]
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

VizyPay Recognized as a Fastest-Growing Company on the Inc. 5000 List for the Fifth Consecutive Year
VizyPay Recognized as a Fastest-Growing Company on the Inc. 5000 List for the Fifth Consecutive Year

Associated Press

time4 hours ago

  • Associated Press

VizyPay Recognized as a Fastest-Growing Company on the Inc. 5000 List for the Fifth Consecutive Year

VizyPay, LLC ('VizyPay'), a leading provider of innovative payment solutions, is proud to announce its inclusion on the Inc. 5000 list of the fastest-growing private companies in America for the fifth year in a row. This year, VizyPay ranks nationally at #4,029, solidifying its position as a dynamic leader in the financial services industry. Waukee, IA - August 17, 2025 - Since its inception, VizyPay has been dedicated to empowering small and medium-sized businesses with seamless, affordable payment processing options. The company's continued growth reflects its commitment to innovation, exceptional customer service, and a relentless focus on meeting the evolving needs of its clients. A Year of Strategic Innovation and Growth This achievement comes on the heels of a significant milestone — VizyPay proudly unveils VEXIS, a proprietary, next-generation Customer Relationship Management (CRM) platform engineered to accelerate enterprise growth, streamline operations, and enhance the user experience for both the organization and its clients. Architected from the ground up, VEXIS enables operational agility, precision, and data-driven performance. The platform marks a strategic leap in VizyPay's innovation roadmap, demonstrating an ongoing commitment to building scalable, future-ready solutions that deliver measurable value for the company, its Sales Partners, and the small businesses they champion. Key Highlights 'We are honored to once again be recognized by Inc. 5000 as one of the fastest-growing companies in the country,' said Austin Mac Nab, CEO of VizyPay. 'This recognition, coming shortly after launching VEXIS, highlights our strategic focus on innovation and operational excellence. Our new CRM is a game-changer, enabling us to serve our clients more effectively while continuing to fuel our growth.' VizyPay's growth trajectory is supported by ongoing expansion efforts, new product launches, and strategic partnerships — all aimed at reinforcing its leadership in the financial technology space. About VizyPay Founded in 2017, VizyPay is a payment technology company dedicated to simplifying payment processing for small and medium-sized businesses. With a focus on transparency, affordability, and personalized service, VizyPay helps merchants grow by providing tailored payment solutions backed by a passionate team committed to their success. For more information, please visit: Media Contact: Jesse James Chief Revenue Officer VizyPay, LLC Phone: 1-888-899-0918 Email: [email protected] VizyPay is proud to be part of the Inc. 5000 community and looks forward to continued growth and innovation in the years Contact Company Name: VizyPay Contact Person: Media Relations Email: Send Email Country: United States Website: Source: Presswire

NextEra Energy (NEE) to Invest $120 Billion in Renewables and Storage Through 2029
NextEra Energy (NEE) to Invest $120 Billion in Renewables and Storage Through 2029

Yahoo

time5 hours ago

  • Yahoo

NextEra Energy (NEE) to Invest $120 Billion in Renewables and Storage Through 2029

We recently published . NextEra Energy, Inc. (NYSE:NEE) is one of these profitable utility stocks. NextEra Energy, Inc. (NYSE:NEE), headquartered in Juno Beach, Florida, is a leading North American electric power and energy infrastructure company. It owns Florida Power & Light Company (FPL), serving about 12 million customers, and NextEra Energy Resources, a top U.S. renewable energy developer with a diverse portfolio including natural gas, nuclear, wind, solar, and battery storage. In 2024 and early 2025, NextEra Energy, Inc. (NYSE:NEE) significantly expanded its renewable energy capacity, adding 8.7 gigawatts of new renewable and storage projects in 2024 and 3.2 gigawatts in Q1 2025. FPL also brought 894 megawatts of new solar capacity online, reinforcing the company's clean energy momentum. The business plans to invest approximately $120 billion over the next four years to grow its fleet to around 121 gigawatts, underscoring its long-term commitment to clean energy and infrastructure growth, and strengthening its case as one of the most profitable stocks in the sector. Strategically, the corporation signed a framework agreement with GE Vernova to develop natural gas power generation solutions, broadening its energy mix to meet evolving customer needs and transition goals. Alongside its renewable focus, NextEra Energy, Inc. (NYSE:NEE)'s regulated utility segment continues to provide reliable electricity and stable earnings, supporting its consistent dividend policy. The board recently declared a quarterly dividend of $0.5665 per share payable in September 2025 and expects to raise dividends by about 10% annually through at least 2026, reflecting strong financial health. With a solid cash position of $1.8 billion in Q2 2025 and robust operating cash flow, the corporation is well-positioned for sustained growth and leadership in the clean energy transition. While we acknowledge the potential of NEE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati

Recursion Pharmaceuticals (RXRX) Expands AI Drug Discovery Pipeline with New Clinical Candid
Recursion Pharmaceuticals (RXRX) Expands AI Drug Discovery Pipeline with New Clinical Candid

Yahoo

time5 hours ago

  • Yahoo

Recursion Pharmaceuticals (RXRX) Expands AI Drug Discovery Pipeline with New Clinical Candid

We recently published . Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best healthcare stocks. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a clinical-stage biotechnology company integrating artificial intelligence (AI), machine learning, and high-throughput biology to accelerate drug discovery, with a focus on oncology and rare diseases. Its proprietary Recursion OS platform streamlines therapeutic identification and development. In July–August 2025, the company acquired full rights to REV102, an oral ENPP1 inhibitor from Rallybio, aimed at treating hypophosphatasia (HPP), a rare genetic disorder with no approved oral disease-modifying therapies. This acquisition expands Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)'s rare disease pipeline and gives it full control over a promising preclinical program. At the same time, the business streamlined its portfolio by discontinuing or pausing several programs, narrowing its focus to six active candidates, four in oncology and two in rare diseases. Its innovative AI-driven platform and pipeline have also drawn attention from investors seeking the best healthcare stocks in biotech. The corporation continues to expand its AI-driven capabilities, most notably through a collaboration with MIT to advance the Boltz-2 AI model on its BioHive-2 platform. This initiative aims to accelerate molecular discovery and synthesis, potentially shortening the path from discovery to clinical trials. The rollout of Recursion OS 2.0 and new partnerships with biopharma and data science firms further enhance its discovery and development capabilities. Copyright: dolgachov / 123RF Stock Photo Upcoming milestones in 2025 include multiple clinical trial initiations and data readouts, such as REC-617, a CDK7 inhibitor in oncology, and REC-4881 for familial adenomatous polyposis. Following its late 2024 merger with Exscientia, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)'s oncology pipeline has broadened, with several candidates expected to advance into human studies. While we acknowledge the potential of RXRX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store